Form 4: Copart CEO Liaw Exercises Options, Sells Shares
Insider Transaction Report
Copart CEO Jeffrey Liaw exercised stock options and subsequently sold a portion of the acquired common stock under a pre-arranged trading plan.
Summary
- Copart, Inc. CEO Jeffrey Liaw engaged in multiple transactions on October 15, 2025, involving the exercise of employee stock options and the sale of common stock.
- Mr. Liaw acquired a total of 49,775 shares of common stock through the exercise of employee stock options at prices of $6.78 and $8.7 per share.
- Following the option exercises, Mr. Liaw sold a total of 24,283 shares of common stock.
- The sales were executed at weighted average prices of $44.8028 and $44.7902 per share.
- All reported sales were conducted automatically pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Liaw on April 15, 2025.
- After these transactions, Mr. Liaw's direct beneficial ownership of common stock stands at 31,332 shares.
- Mr. Liaw also holds remaining employee stock options to buy 32,809 shares at $6.78 and 623,505 shares at $8.7.
Sentiment
Score: 5
Explanation: The transactions represent routine insider activity under a pre-arranged 10b5-1 trading plan, which is generally considered neutral in terms of market sentiment as it does not reflect new discretionary decisions about the company's prospects.
Positives
- The CEO exercised a significant number of employee stock options, indicating a realization of value from long-term incentives.
- Substantial profit was realized from the difference between the low exercise prices ($6.78 and $8.7) and the higher sale prices (approximately $44.80 per share).
Negatives
- Insider selling, even if pre-arranged, can sometimes be perceived negatively by the market, although the 10b5-1 plan mitigates this concern.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May observe the insider selling, but the pre-arranged 10b5-1 plan typically mitigates concerns about management's immediate view of the company's future.
Key Dates
| Date | Description |
|---|---|
| 10/10/2017 | Grant date for certain employee stock options. |
| 10/04/2018 | Grant date for certain employee stock options. |
| 04/15/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 10/15/2025 | Date of reported transactions (option exercises and stock sales). |
| 10/17/2025 | Date the Form 4 filing was signed. |
| 10/10/2026 | Expiration date for certain employee stock options. |
| 10/04/2027 | Expiration date for certain employee stock options. |
Recommendation
holdThe filing details routine insider transactions by the CEO, including option exercises and subsequent sales, executed under a pre-arranged Rule 10b5-1 trading plan. This type of activity is generally not considered a strong indicator of future company performance or a reason to alter investment strategy, thus a 'hold' recommendation is appropriate.
Keywords
Copart, CPRT, Insider Trading, Form 4, Stock Options, CEO, Jeffrey Liaw, Stock Sale, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.